Throughout this period, the ability to overcome the most common side effect of cancer drugs, myelosuppression (a decrease in blood counts), improved dramatically. It began with the ability to transfuse not only red blood cells into anemic patients, but also platelets, reducing the threat of life-threatening bleeding that can accompany cancer therapy.
在此期间，克服骨髓抑制（即导致血细胞计数减少）这种最常见的抗癌药物副作用的技术得到了显著提高。现在可以将红血球和血小板同时输入到贫血患者体内，从而缓解癌症治疗引发的危及生命的出血现象。